Global Information
회사소개 | 문의 | 위시리스트

세계의 관절내 점성보충 시장 분석과 예측 : 제품별, 지역별

Viscosupplementation Market By Product (Single injection, Three injection, Five injection), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2015 - 2026

리서치사 Grand View Research, Inc.
발행일 발행예정 상품 코드 557208
페이지 정보 영문
가격
US $ 5,950 ₩ 7,043,000 Unprintable PDF by E-mail (Single User License)
US $ 6,950 ₩ 8,227,000 Printable PDF by E-mail (5-User License)
US $ 8,950 ₩ 10,595,000 Printable PDF by E-mail (Enterprise License)

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 관절내 점성보충 시장 분석과 예측 : 제품별, 지역별 Viscosupplementation Market By Product (Single injection, Three injection, Five injection), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2015 - 2026
발행일 : 발행예정 페이지 정보 : 영문

세계의 관절내 점성보충(Viscosupplementation) 시장에 대해 분석했으며, 질환·제품 개요와 시장의 기본 구조·최신 상황, 주요 시장 성장 촉진·억제요인, 전체적인 시장 규모 동향 전망(과거 3년간, 향후 9년간), 제품별·지역별 동향, 주요 기업 개요·실적 등의 정보를 전해드립니다.

제1장 조사 방법

제2장 주요 요약

제3장 시장 개요

제4장 관절내 점성보충 시장 : 변수, 동향, 범위

  • 시장 세분화와 범위
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
  • 제품 보급률 및 시장 성장률 전망 : 매핑
  • PESTEL 분석
  • Porter's Five Forces 분석
  • 경쟁 구도 : 시장 포지션 분석(제품 포트폴리오 및 지역별 입지 기반)

제5장 관절내 점성보충 시장 : 제품별 예측과 동향 분석

  • 제품별 시장 동향 분석
  • 단회 투여 제품
  • 3회 투여 제품
  • 5회 투여 제품

제6장 관절내 점성보충 시장 : 지역별 예측과 동향 분석

  • 지역별 시장 점유율(금액 기준, 최신·예측)
  • 북미(미국, 캐나다)
  • 유럽(영국, 프랑스)
  • 아시아태평양(일본, 중국)
  • 라틴아메리카(브라질, 멕시코)
  • 중동 및 아프리카(남아프리카공화국)

제7장 의료비 상환 상황 전망

  • 제품별 의료비 상환 상황
    • Gel-one
    • EUFLEXXA
    • Synvisc-One
    • Supartz
    • Hyalgan
    • Monovisc
    • Orthovisc

제8장 경쟁 구도

  • 경쟁 체계
  • 기업 개요
KSM 17.10.11

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

The global viscosupplementation market is expected to reach USD 6.52 billion by 2025, based on a new report by Grand View Research, Inc. The market is expected to observer an exponential growth over the next 9 years due to the increasing incidence of osteoarthritis, wounds, gingivitis, & ulcers and growing base of the geriatric population are some high-impact rendering drivers of the viscosupplements market.

Estimates published by the WHO suggest that the global population of the age group 65 years and above is anticipated to rise from 7% in 2000 to 16% in 2050. An associated consequence of this increase in the geriatric population will be an increase in the incidence of obesity and osteoarthritis. Along with growing preference for minimally invasive surgeries, global increase in the target population is expected to significantly propel demand for viscosupplementations throughout the forecast period.

Further key findings from the report suggest:

  • Three injection dominated the market in 2016, closely followed by single injection. It can be owing to the prolonged presence and holding a significant share of this market.
  • Single injection is anticipated to be one of the fastest growing segment owing to the increase in convenience, reduced hospital visits, and reduced adverse effects & associated pain
  • Geographically, Asia Pacific held the largest market share in 2016 and is expected to maintain its position during the forecast period. This large share can be accounted for by the presence of a sizeable base of geriatric population, which is more susceptible to disorders such as osteoarthritis and rheumatoid arthritis. Moreover, growing demand for minimally invasive procedures is a significant factor contributing to the large share of Asia Pacific.
  • Due to the presence of high unmet medical needs in emerging economies, such Brazil, growing awareness about applications of minimally invasive techniques, and increasing disposable income, the Latin American market is expected to grow at a lucrative rate in the coming years

Some key industry contributors are Sanofi, Anika Therapeutics, Inc., Seikagaku Corporation, Zimmer Holdings Inc, Bioventus, Ferring B.V., Lifecore Biomedical, LLC, and LG Life Sciences Ltd

Table of Content

Chapter 1 Research Methodology

  • 1.1 Information Procurement
  • 1.2 Data Analysis

Chapter 2 Executive Summary

Chapter 3 Market Snapshot

Chapter 4 Viscosupplementation Market Variables, Trends& Scope

  • 4.1 Market Segmentation and Scope
    • 4.1.1 Market Driver Analysis
      • 4.1.1.1 Increasing geriatric population
      • 4.1.1.2 High prevalence of orthopedic disorders
    • 4.1.2 Market Restraint Analysis
      • 4.1.2.1 High cost and side effects associated with hyaluronic acid cycles
  • 4.2 Penetration & Growth Prospects Mapping
  • 4.3 Viscosupplementation Market - PESTLE Analysis
  • 4.4 Industry Analysis - Porter's
  • 4.5 Viscosupplementation Competitive Landscape: Market position analysis (based on products, regional presence

Chapter 5 Viscosupplementation Market: Product Estimates & Trend Analysis

  • 5.1 Viscosupplementation Market: Product Movement Analysis
  • 5.2 Single Injection
    • 5.2.1 Single-injection market, 2014 - 2025 (USD Million)
  • 5.3 Three Injection
    • 5.3.1 Three-injection market, 2014 - 2025 (USD Million)
  • 5.4 Five Injection
    • 5.4.1 Five-injection market, 2014 - 2025 (USD Million)

Chapter 6 Viscosupplementation Market: Regional Estimates & Trend Analysis, by Product

  • 6.1 Viscosupplementation Market Share, by Region, 2016 & 2025
  • 6.2 North America
    • 6.2.1 U.S.
      • 6.2.1.1 U.S. viscosupplementation market, 2014 - 2025 (USD Million)
    • 6.2.2 Canada
      • 6.2.2.1 Canada viscosupplementation market, 2014 - 2025 (USD Million)
  • 6.3 Europe
    • 6.3.1 UK
      • 6.3.1.1 UK viscosupplementation market, 2014 - 2025 (USD Million)
    • 6.3.2 France
      • 6.3.2.1 France viscosupplementation market, 2014 - 2025 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific viscosupplementation market, 2014 - 2025 (USD Million)
    • 6.4.2 Japan
      • 6.4.2.1 Japan viscosupplementation market, 2014 - 2025 (USD Million)
    • 6.4.3 China
      • 6.4.3.1 China viscosupplementation market, 2014 - 2025 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Latin America viscosupplementation market, 2014 - 2025 (USD Million)
    • 6.5.2 Brazil
      • 6.5.2.1 Brazil viscosupplementation market, 2014 - 2025 (USD Million)
    • 6.5.3 Mexico
      • 6.5.3.1 Mexico viscosupplementation market, 2014 - 2025 (USD Million)
  • 6.6 MEA
    • 6.6.1 MEA viscosupplementation market, 2014 - 2025 (USD Million)
    • 6.6.2 South Africa
      • 6.6.2.1 South Africa viscosupplementation market, 2014 - 2025 (USD Million)

Chapter 7 Reimbursement Outlook

  • 7.1 Reimbursement by Product
    • 7.1.1 Gel-one
    • 7.1.2 EUFLEXXA
    • 7.1.3 Synvisc-One
    • 7.1.4 Supartz
    • 7.1.5 Hyalgan
    • 7.1.6 Monovisc
    • 7.1.7 Orthovisc

Chapter 8 Competitive Landscape

  • 8.1 Strategy Framework
  • 8.2 Company Profiles
    • 8.2.1 Sanofi
      • 8.2.1.1 Company overview
      • 8.2.1.2 Financial performance
      • 8.2.1.3 Product benchmarking
      • 8.2.1.4 Strategic initiatives
    • 8.2.2 Anika Therapeutics, Inc.
      • 8.2.2.1 Company overview
      • 8.2.2.2 Financial performance
      • 8.2.2.3 Product benchmarking
      • 8.2.2.4 Strategic initiatives
    • 8.2.3 Seikagaku Corporation
      • 8.2.3.1 Company overview
      • 8.2.3.2 Financial performance
      • 8.2.3.3 Product benchmarking
      • 8.2.3.4 Strategic initiatives
    • 8.2.4 Zimmer Biomet
      • 8.2.4.1 Company overview
      • 8.2.4.2 Financial performance
      • 8.2.4.3 Product benchmarking
      • 8.2.4.4 Strategic initiatives
    • 8.2.5 Smith & Nephew Plc
      • 8.2.5.1 Company overview
      • 8.2.5.2 Financial performance
      • 8.2.5.3 Product benchmarking
      • 8.2.5.4 Strategic initiatives
    • 8.2.6 Ferring B.V.
      • 8.2.6.1 Company overview
      • 8.2.6.2 Product benchmarking
      • 8.2.6.3 Strategic initiatives
    • 8.2.7 Lifecore Biomedical, LLC
      • 8.2.7.1 Company overview
      • 8.2.7.2 Financial performance
      • 8.2.7.3 Product benchmarking
      • 8.2.7.4 Strategic initiatives
    • 8.2.8 LG Life Sciences Ltd
      • 8.2.8.1 Company overview
      • 8.2.8.2 Product benchmarking
      • 8.2.8.3 Strategic initiatives

List of Tables

  • TABLE 1 North America Viscosupplementation Market, by Country, 2014 - 2025 (USD Million)
  • TABLE 2 North America Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
  • TABLE 3 U.S. Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
  • TABLE 4 Canada Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
  • TABLE 5 Europe Viscosupplementation Market, by Country, 2014 - 2025 (USD Million)
  • TABLE 6 Europe Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
  • TABLE 7 UK Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
  • TABLE 8 France Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
  • TABLE 9 Asia Pacific Viscosupplementation Market, by Country, 2014 - 2025 (USD Million)
  • TABLE 10 Asia Pacific Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
  • TABLE 11 Japan Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
  • TABLE 12 China Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
  • TABLE 13 Latin America Viscosupplementation Market, by Country, 2014 - 2025 (USD Million)
  • TABLE 14 Latin America Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
  • TABLE 15 Brazil Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
  • TABLE 16 Mexico Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
  • TABLE 17 MEA Viscosupplementation Market, by Country, 2014 - 2025 (USD Million)
  • TABLE 18 MEA Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
  • TABLE 19 South Africa Viscosupplementation Market, by Product, 2014 - 2025 (USD Million)
  • TABLE 20 Cost of viscosupplementations- A driving factor (US)
  • TABLE 21 NYS non-coverage details
  • TABLE 22 HCPCS Code
  • TABLE 23 Labeling Instructions by the FDA
  • TABLE 24 Distribution and marketing rights of Synvisc

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing &forecasting
  • FIG. 6 QFD modeling for market share assessment
  • FIG. 7 Market summary
  • FIG. 8 Market trends & outlook
  • FIG. 9 Market segmentation & scope
  • FIG. 10 Market driver relevance analysis (Current & future impact)
  • FIG. 11 Ratio of adult population to total population (billion)
  • FIG. 12 Market restraint relevance analysis (Current &future impact)
  • FIG. 13 Penetration & growth prospect mapping
  • FIG. 14 Viscosupplementation Market - PESTLE Analysis
  • FIG. 15 Porter's Five Forces Analysis
  • FIG. 16 Viscosupplementation market: Heat map analysis
  • FIG. 17 Viscosupplementation market product outlook key takeaways
  • FIG. 18 Viscosupplementation market: Product movement analysis
  • FIG. 19 Global single-injection market, 2014 - 2025 (USD Million)
  • FIG. 20 Global three-injection market, 2014 - 2025 (USD Million)
  • FIG. 21 Global five-injection market, 2014 - 2025 (USD Million)
  • FIG. 22 Regional market place: Key takeaways
  • FIG. 23 Regional outlook, 2016 & 2025
  • FIG. 24 North America viscosupplementation market, 2014 - 2025 (USD Million)
  • FIG. 25 U.S. viscosupplementation market, 2014 - 2025 (USD Million)
  • FIG. 26 Canada viscosupplementation market, 2014 - 2025 (USD Million)
  • FIG. 27 Europe viscosupplementation market, 2014 - 2025 (USD Million)
  • FIG. 28 UK viscosupplementation market, 2014 - 2025 (USD Million)
  • FIG. 29 France viscosupplementation market, 2014 - 2025 (USD Million)
  • FIG. 30 Asia Pacific viscosupplementation market, 2014 - 2025 (USD Million)
  • FIG. 31 Japan viscosupplementation market, 2014 - 2025 (USD Million)
  • FIG. 32 China viscosupplementation market, 2014 - 2025 (USD Million)
  • FIG. 33 Latin America viscosupplementation market, 2014 - 2025 (USD Million)
  • FIG. 34 Brazil viscosupplementation market, 2014 - 2025 (USD Million)
  • FIG. 35 Mexico viscosupplementation market, 2014 - 2025 (USD Million)
  • FIG. 36 MEA viscosupplementation market, 2014 - 2025 (USD Million)
  • FIG. 37 South Africa viscosupplementation market, 2014 - 2025 (USD Million)
  • FIG. 38 Strategy framework
Back to Top
전화 문의
F A Q